Global Genomic Data Analysis and Interpretation Market Insights, Forecast to 2028

The market is favored by the developments in the field of genomics and bioinformatics. Currently, the genomic data analysis and interpretation industry is witnessing an upsurge due to the growing number of genomic research initiatives being undertaken by the developing and developed countries coupled with the decreasing cost of sequencing, resulting in the high demand for software solutions for genomic data analysis. Additionally, high adoption of sequencing instruments by the researchers and clinicians, coupled with the growing prevalence of complex diseases, such as cancer, are some of the critical factors expected to bolster the market growth.
Market Analysis and Insights: Global Genomic Data Analysis and Interpretation Market
The global Genomic Data Analysis and Interpretation market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Next-Generation Sequencing (NGS) accounting for % of the Genomic Data Analysis and Interpretation global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research and Academic Institutions segment is altered to an % CAGR throughout this forecast period.
China Genomic Data Analysis and Interpretation market size is valued at US$ million in 2021, while the North America and Europe Genomic Data Analysis and Interpretation are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Genomic Data Analysis and Interpretation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomic Data Analysis and Interpretation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomic Data Analysis and Interpretation market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomic Data Analysis and Interpretation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomic Data Analysis and Interpretation market.
Global Genomic Data Analysis and Interpretation Scope and Market Size
Genomic Data Analysis and Interpretation market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Genomic Data Analysis and Interpretation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Other Genomic Platforms
Segment by Application
Research and Academic Institutions
Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Contract Research Organizations
Forensic Laboratories
Other End Users
By Company
10x Genomics
Agilent Technologies
ASURAGEN INC
Beijing Genomics Institute (BGI)
Genomics
Bio-Rad Laboratories
DNASTAR
F. Hoffmann-La Roche Ltd
Golden Helix
Illumina
Oxford Nanopore Technologies
Pacific Biosciences of California
Partek
QIAGEN N.V.
SoftGenetics LLC
Thermo Fisher Scientific Inc.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA